International Clinical Trial: PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813351) titled 'PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University College, London

Condition: Acromegaly Due to Pituitary Adenoma Cushing's Disease Pituitary Adenoma

Intervention: Radiation: Standard dose Intensity-Modulated Radiation Therapy (IMRT) Radiation: Standard dose Proton Beam Therapy (PBT)

Recruitment Status: No...